Histomorphometric Analysis of Osseointegrated Intraosseous Dental Implants Using Undecalcified Specimens: A Scoping Review Authors: Stefan Peev, Ralitsa Yotsova, Ivaylo Parushev, Hermann Ehrlich Published: 2024 ABSTRACT AbstractBone histology and histomorphometry are reliable diagnostic tools for the assessment of the bone–implant interface, material safety and biocompatibility, and tissue response. They allow for the qualitative and quantitative analysis of undecalcified bone specimens. This scoping review aims to identify the most common staining techniques, study models for in vivo experiments, and histomorphometric parameters used for quantitative bone evaluation of osseointegrated dental implants in the last decade. The Web of Science, PubMed, and Scopus databases were searched on 1 July 2024 for relevant articles in English, published in the last ten years, and the data were exported to an MS Excel spreadsheet. A total of 115 studies met the eligibility criteria and were included in the present review. The results indicate that the most common study models are dogs, rabbits, and pigs. Some of the most frequently used methods for the assessment of the bone–implant interface are the Toluidine blue, Stevenel’s blue with Van Gieson, and Levai–Laczko stainings. The results from this study demonstrate that the most commonly used histomorphometric parameters in implant dentistry are the bone-to-implant contact (BIC), bone area fraction occupancy (BAFO), bone area (BA), and bone density (BD). This review presents the recent trends in histomorphometric analysis of dental implants and identifies some research gaps that necessitate further research.Keywords: histology, histomorphometry, undecalcified, non-decalcified, dental implant, osseointegration 1. Introduction Replacing missing dental tissue with prosthetic constructions supported by root-form implants is a biomimetic approach to rehabilitating the dentition impaired by pathological processes. Dental implant placement is a routine procedure that has been widely recognized as a treatment modality of choice for restoring missing teeth [1]. Intraosseous dental implants made of commercially pure titanium are still regarded as the gold standard [2] and are the most commonly used dental implants due to their high success rate of up to 99% [3,4]. The alternatives to titanium implants include implants made of titanium alloys, zirconia, a combination of titanium and zirconia, and implants with various coatings, which have demonstrated excellent tissue behavior and survival rates [5,6,7,8]. The foundation of contemporary dental implantology was laid by Brånemark et al. [9,10], who found evidence of direct bone apposition on implant surfaces—a phenomenon that was later referred to as “osseointegration”. Osseointegration is a biomimetic rather than a physiological process. It was first defined as “direct contact between a loaded implant surface and bone at a light microscopic level” [11]. It was later defined as the “clinically asymptomatic rigid fixation of alloplastic materials”, which is “achieved and maintained in bone during functional loading” [12]. As described by John Davis, the third phase of contact osteogenesis is a biomimetic process resembling bone remodeling [13]. In this sense, the analysis of the parameters that are the subject of the present study represents a biomimetic process replicating the bone remodeling triggered by trauma. Osseointegration is a dynamic process initiated during implant placement, with primary implant stability leading to secondary stability [14]. It is still unknown to what extent an implant should be in direct contact with vital bone to be regarded as “osseointegrated”. There are no exact criteria for the evaluation of this process. Moreover, bone is a vital and dynamic tissue that undergoes constant remodeling [15,16]. Therefore, it requires not only static but also dynamic assessment. It has become evident that implant material, design, and surface characteristics have key impacts on osseointegration success. In the last decades, various biomaterials, implant designs, and coatings have been developed and evaluated in order to improve long-term treatment results [17,18,19]. Furthermore, numerous analytical techniques and clinical and paraclinical tests have been utilized for the assessment of the osseointegration process and implant stability, such as torque tests, resonance frequency analysis, fractal analysis, computed tomography (CT), cone-beam CT, micro-CT, scanning electron microscopy, transmission electron microscopy, Raman spectroscopy, histological evaluation, histomorphometric analysis, immunohistochemistry, and so on [20,21,22,23,24]. It has been evident that implant material, design, and surface characteristics have key impacts on osseointegration success. In the last decades, various biomaterials, implant designs, and coatings have been developed and evaluated in order to improve long-term treatment results [17,18,19]. Light optical microscopy is a commonly utilized diagnostic tool for the observation of biopsy specimens and the evaluation of material behavior and tissue responses. It allows for both qualitative (histological) and quantitative (histomorphometric) assessment. Qualitative histology provides a detailed description of tissues and their morphology, maturity, and cellular and non-cellular components [25,26,27]. Bone histomorphometry is the gold standard for the evaluation of bone density, implant stability and osseointegration, material behavior, and tissue response [13,28]. Until the middle of the 20th century, the histological evaluation of bone necessitated its prior decalcification. The introduction of plastic embedding allowed for a more precise assessment of undecalcified bone specimens [27,29]. Histomorphometric assessment can be divided into two major groups: static and dynamic histomorphometry. Examples of static histomorphometric parameters are bone-to-implant contact (BIC), bone density (BD), and the amount and characteristics of the cellular content, whereas examples of dynamic parameters are mineral apposition rate and fluorescence analysis [30,31,32]. Dynamic parameters are evaluated after fluorochrome labeling, which allows for the visualization of bone remodeling [32,33,34]. The most commonly evaluated histomorphometric parameter is BIC [35]. It is described as “the percentage of implant surface in direct contact with bone tissue” [13,36]. However, numerous studies do not specify what type of bone (new, old, or total) covers the implant when calculating BIC. In addition, it is still not clear if BIC is informative enough to serve as a marker of implant stability [37], although it is used for the evaluation of the speed of new bone deposition. It is a well-known fact that implant stability depends on several factors, including the percentage of BIC, the type of connection between the new bone deposited on the implant surface and the surrounding bone, and bone density [13,38]. The region of interest (ROI) is not a strictly defined term and depends on the evaluated parameters and the research objectives. For instance, when BIC is assessed, the ROI can trace the whole implant perimeter and the areas that demonstrate bone deposition on the implant surface (%BIC = length of BIC/total perimeter length of the implant) [31,39,40,41]. In contrast, some studies use only one implant thread at a time as an ROI [42,43,44]. Numerous staining methods have been developed and introduced, and most of them allow for excellent histological evaluation [28]. However, these methods tend to stain different structures in similar colors and shades, which makes computer-assisted assessment extremely challenging. Although hand tracing is possible in such cases, the process is labor-intensive and time-consuming [36]. Toluidine blue has been reported as the most common staining technique for the histological evaluation of dental implant osseointegration [35]. Microscopic observation of the interaction between bone, bone substitutes, and dental implants through animal experiments has become a common research strategy for the evaluation of material behavior and cellular and tissue responses. Animals are commonly used as in vivo models in biomedical and biomaterials sciences due to the impossibility of such experiments on humans. The selection of appropriate animal species that resemble human biology, physiology, and pathophysiology is a crucial criterion for obtaining results that are transferable to clinical applications [25,45]. Various animal models have been used in the existing scientific literature for in vivo testing of implant osseointegration, material behavior, safety and efficacy, and the tissue response to biomaterials, implants, and coatings [14,46]. These studies, however, present a high degree of heterogeneity due to interspecies differences, different work protocols, implant characteristics, loading conditions, and so on. Therefore, a direct comparison between them is not feasible [14]. It has been suggested that irrespective of the animal model (dog, rat, rabbit, pig, goat, sheep, or monkey) or the selected surgical site, studies can provide valuable results when properly designed [30]. The present review discusses the histomorphometric assessment of osseointegrated intraosseous dental implants using undecalcified bone specimens. It aims to identify the most frequently used staining methods, study models, and histomorphometric parameters (study variables) for the histomorphometric analysis of intraosseous dental implants in recent years. The study analyzes their advantages and limitations, identifies some research gaps, and gives recommendations for further research. To the best of our knowledge, this is the first scoping review that identifies the recent trends in the histomorphometric analysis of dental implants regarding these variables. Implant dentistry is a rapidly developing field and, recently, researchers have been focused on introducing new biomimetic materials, scaffolds, surface modifications, and implant coatings [47,48,49,50]. Their accurate evaluation requires appropriate and reliable histological and histomorphometric protocols. The results of this study indicate a lack of unification of the specific terminology and clear guidelines for applying the existing protocols for histomorphometric observations, which is a major drawback, necessitating further research and evaluation. 2. Materials and Methods This scoping review adhered to the PCC framework with the following components. P (Patient/Population/Participants)—Study models (human and animal) used for the evaluation of dental implant osseointegration C (Concept)—Types of staining techniques and histomorphometric parameters C (Context)—Research articles published in the last 10 years (2014–2024) Review Question: What types of staining techniques and histomorphometric parameters (C) are used in the different study models (human and animal) for the evaluation of dental implant osseointegration (P) in the last 10 years (C)? Review Question: What types of staining techniques and histomorphometric parameters (C) are used in the different study models (human and animal) for the evaluation of dental implant osseointegration (P) in the last 10 years (C)? Eligibility Criteria The inclusion criteria were as follows: original research articles; articles that evaluated dental implant osseointegration using undecalcified plastic-embedded specimens; and articles that reported the study models and histological stainings used. The exclusion criteria were as follows: 1. review articles, books, book chapters, and abstracts; 2. articles that did not discuss undecalcified plastic-embedded specimens; 3. articles that did not include histological staining; 4. articles that did not discuss histomorphometric parameters; 5. articles that did not discuss osseointegrated intraosseous dental implants; 6. articles from before 2014. Information Sources This scoping review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analysis for Scoping Reviews (PRISMA-ScR) [51]. It was registered in the Open Science Framework (OSF) and can be found at https://archive.org/details/osf-registrations-9b8yx-v1 (accessed on 12 July 2024). A comprehensive electronic search for research articles in the Web of Science, PubMed, and Scopus databases was conducted on 1 July 2024. Search Strategy The search strategy comprised an advanced search in the selected databases using combinations of keywords and MeSH Terms. It encompassed articles published in the last 10 years to capture the most up-to-date evidence on the topic and present the recent trends in the field. The keywords that were used in the Web of Science database were: ALL = (((histology) OR (histomorphometry)) AND ((undecalcified) OR (non-decalcified)) AND (dental implant) AND (osseointegration)). The keywords that were used in the Web of Science database were: ALL = (((histology) OR (histomorphometry)) AND ((undecalcified) OR (non-decalcified)) AND (dental implant) AND (osseointegration)). The keywords that were used in the PubMed database were: ((histology) OR (histomorphometry)) AND ((undecalcified) OR (non-decalcified)) AND (dental implant) AND (osseointegration).The expanded query string was: (“anatomy and histology” [MeSH Subheading] OR (“anatomy” [All Fields] AND “histology” [All Fields]) OR “anatomy and histology” [All Fields] OR “histology” [All Fields] OR “histology” [MeSH Terms] OR “histologies” [All Fields] OR “histomorphometry” [All Fields]) AND (“undecalcified” [All Fields] OR “non-decalcified” [All Fields]) AND (“dental implants” [MeSH Terms] OR (“dental” [All Fields] AND “implants” [All Fields]) OR “dental implants” [All Fields] OR (“dental” [All Fields] AND “implant” [All Fields]) OR “dental implant” [All Fields]) AND (“osseointegrate” [All Fields] OR “osseointegrated” [All Fields] OR “osseointegrates” [All Fields] OR “osseointegrating” [All Fields] OR “osseointegration” [MeSH Terms] OR “osseointegration” [All Fields] OR “osseointegrative” [All Fields]). The keywords that were used in the PubMed database were: ((histology) OR (histomorphometry)) AND ((undecalcified) OR (non-decalcified)) AND (dental implant) AND (osseointegration). The expanded query string was: (“anatomy and histology” [MeSH Subheading] OR (“anatomy” [All Fields] AND “histology” [All Fields]) OR “anatomy and histology” [All Fields] OR “histology” [All Fields] OR “histology” [MeSH Terms] OR “histologies” [All Fields] OR “histomorphometry” [All Fields]) AND (“undecalcified” [All Fields] OR “non-decalcified” [All Fields]) AND (“dental implants” [MeSH Terms] OR (“dental” [All Fields] AND “implants” [All Fields]) OR “dental implants” [All Fields] OR (“dental” [All Fields] AND “implant” [All Fields]) OR “dental implant” [All Fields]) AND (“osseointegrate” [All Fields] OR “osseointegrated” [All Fields] OR “osseointegrates” [All Fields] OR “osseointegrating” [All Fields] OR “osseointegration” [MeSH Terms] OR “osseointegration” [All Fields] OR “osseointegrative” [All Fields]). The keywords that were used in the Scopus database were: ((histology) OR (histomorphometry)) AND ((undecalcified) OR (non-decalcified)) AND (dental AND implant) AND (osseointegration) AND PUBYEAR > 2013 AND PUBYEAR < 2025 AND (LIMIT-TO (DOCTYPE, “ar”)) AND (LIMIT-TO (LANGUAGE, “English”)). The keywords that were used in the Scopus database were: ((histology) OR (histomorphometry)) AND ((undecalcified) OR (non-decalcified)) AND (dental AND implant) AND (osseointegration) AND PUBYEAR > 2013 AND PUBYEAR < 2025 AND (LIMIT-TO (DOCTYPE, “ar”)) AND (LIMIT-TO (LANGUAGE, “English”)). Study Selection, Data Collection, and Data Items The titles, abstracts, author names, and years of publication of the studies were exported to an MS Excel spreadsheet. Then, duplicate records were removed. Titles and abstracts were screened and evaluated for eligibility by two independent reviewers (R.Y. and I.P.) and then the full-text studies were subjected to the inclusion and exclusion criteria. The data retrieved from each article included authors and year of publication, study models, sample size, implant material, healing time, staining technique, augmentation (if performed), and histomorphometric parameters. In addition, the definitions of ROI were extracted, if present. Discrepancies among the reviewers were resolved through discussion, consensus, and arbitration by a third reviewer (S.P.) when a consensus between the first two was difficult to reach. Synthesis Methods Each study was evaluated by two independent reviewers (R.Y. and I.P.) and the data were synthesized in tables in MS Excel Spreadsheets. Decisions about articles with missing data were made through discussion until a consensus was reached. 3. Results The initial search identified 294 potentially relevant studies from the three electronic databases over the last ten years. After the exclusion of 29 duplicate records, 265 articles remained. Then, the articles that did not meet the eligibility criteria were excluded. Finally, a total of 115 studies were included in the present review. Figure 1 illustrates a PRISMA flow chart of the selection process [52]. PRISMA flow diagram of the research [52]. Table 1 presents the characteristics of the studies included in this scoping review. Table 1Articles included in the present study.№ReferenceAuthorsYearStudy ModelSample SizeImplant MaterialHealing TimeStaining MethodAugmentationHistomorphometric Parameters1[53]Adam et al.2014Rabbit36Titanium2, 4, 6 weeksToluidine blueNoBIC2[54]Alayan et al.2017Sheep16Titanium2, 4 weeksToluidine blueYesBIC, WB, LB, RG, STM3[55]Alenezi et al.2019Rat96Titanium2, 6 weeksToluidine blue-pyroninNoBIC, BA, new-BA4[56]Almohandes et al.2019Dog24Titanium24 weeksToluidine blue and fibrin stain of LadewigYes NoBIC5[57]Al-Omari et al.2020Rabbit80Titanium4, 6, 8, 10 weeksToluidine blueNoBIC, BAF, Ct.Th6[58]Alshehri et al.2019Goat36Titanium7 weeksMethylene blue and basic fuchsineYes NoPIBA7[59]Baires-Campos et al.2015Dog40Titanium2, 4 weeksToluidine blueNoBIC, BAFO8[60]Beutel et al.2016Dog72Not stated3, 5 weeksToluidine blueNoBIC, BAFO9[61]Boldeanu et al.2022Dog5Titanium11 monthsMasson Goldner Anilin blue; MOVAT Pentachrome (after Verhöff)Noimp-BC, IS-BC, IS-BD, BC-BD10[62]Boldeanu et al.2023Dog5Titanium11 monthsMasson Goldner Anilin blue; MOVAT Pentachrome (after Verhöff)Noimp-BC, IS-BC, IS-BD, BC-BD11[63]Botzenhart et al.2015Minipig15Titanium8 weeksMasson-Goldner-trichromeNoBIC12[64]Bowers et al.2016Sheep24Titanium6 weeksStevenel’s Blue and Van Gieson´s Picro FuschinNoBIC, BAFO13[65]Calvo-Guirado et al.2015Dog48Titanium30, 90 daysToluidine blueNoBIC, CBL14[66]Calvo-Guirado J.2015Dog48Titanium12 weeksToluidine blueNoBIC, CBL15[67]Chien et al.2014Dog12Titanium2 monthsStevenel blue and Van Gieson picro fuchsinNoBIC16[68]Chiu et al.2018Human52Titanium6, 8 monthsStevenel blue and Van Gieson picro fuchsinYesBIC, MIC, CTIC17[69]Cho et al.2019Rabbit16Titanium2 weeksmodified Goldner’s Masson trichromeNoBIC, BA18[70]Choi et al.2018Rabbit24Titanium10 daysAlizarin red; Masson-Goldner trichromeNoBIC, BA19[71]Coelho et al.2014Rat40Titanium1, 2, 4, 8 weeksNot statedNoBIC, BAFO20[72]Coelho et al.2014Dog306Titanium1, 2, 4 weeksToluidine blue; Stevenel’s blue and van GiesonNoBIC, BAFO21[73]Cohen et al.2016Rabbit40Titanium42 daysToluidine blueNoc-BIC, t-BIC22[74]Dagher et al.2014Sheep32Titanium1, 2 monthsGiemsa-ParagonNoBIC, ISB, ISA23[75]de Barros et al.2015Dog48Titanium8 weeksToluidine blueNoBIC, BD, IS-BIC, HBA, IS-BC, CR, BR24[76]De Barros et al.2014Minipig52Titanium8 weeksStevenel’s blue and Alizarin red SNoBIC, BD, BR-I, BR-FE, CBR25[77]De Jesus et al.2016Dog24Titanium2, 4 weeksToluidine blue; van Giessons pichro fuchsinNoBIC, BD26[78]De Deco et al.2015Rat27Titanium30 daysToluidine blueNoBIC27[79]De Val et al.2017Dog80Titanium4, 8 weeksToluidine blueNoBIC28[80]Du et al.2016Rat42Titanium3, 7, 14, 28, 56 daysmethylene blue-alizarin red SNoBIC, new BA29[81]Du et al.2016Rat64Titanium3, 7, 14, 28 daysmethylene blue-alizarin red SNoBIC, new BA30[82]Dundar et al.2018Rat40Titanium12 weeksToluidine blueNoBIC31[83]Elmali et al.2020Rabbit24Titanium28 daysToluidine blueYesBIC32[84]Erdogan et al.2013Pig9Titanium8 weeksToluidine blueNoBIC, BV/TV, TbTh, TbSp33[85]Felgueiras et al..2017Rabbit84Titanium4, 12, 48 weeksStevenel blue and van Gieson PicrofuschinNoBIC, BA34[86]Fernández-Domínguez et al.2019Dog48Titanium3 monthspicro-syrius-hematoxylinYesBIC, CBL35[87]Fetner et al.2015Dog36Titanium6 monthsStevenel blue and van Gieson fuschinNoBIC, BAFO36[88]Freitas et al.2016Rabbit36Titanium2, 6 weeks Stevenel’s blue and Alizarin redNoBIC, BABT, BAMA37[89]Gabler et al.2015Rat15Titanium6 weeksToluidine blueNoBIC38[90]Galárraga-Vinueza et al.2020Human5Titanium5.1, 10, 15, 20.3, yearsLevai–LaczkoNoBIC, BD, DL, RB39[91]Galli et al.2016Rabbit40Titanium6 weeksToluidine blue-pyroninNoBIC, BA, NBA40[92]Gil et al.2016Dog48Titanium1, 6 weeksStevenel’s blue and van GiesonNoBIC, BAFO41[93]Gil et al.2017Dog48Titanium3, 5 weeksStevenel’s blue and van GiesonNoBIC; BAFO42[94]Gil et al.2015Human93Titanium120 days to 18 yearsToluidine blueNoBIC, BAFO43[95]Görmez et al.2015Pig24Titanium10 weeksToluidine blueYes NoBIC, BF, RG44[96]Guillaume et al.2021Rabbit8Titanium12 weeksvan Gieson picro-fuchsin and Stevenel’s blueNoBIC45[97]Gurzawska et al.2017Rabbit128Titanium2, 4, 6, 8 weeksToluidine blueNoBIC, BD46[98]Herrero-Climent et al.2018Minipig48Titanium2, 4, 8 weeksToluidine blueNoBIC, BAD47[99]Hirota et al.2014Rabbit12Zirconia12 weeksMethylene blue and basic Fuchsin;NoBIC, BM48[100]Hong et al.2014Rabbit6Titanium1 weekHematoxylin and EosinNoBIC, BA49[101]Hoornaert et al.2020Minipig60Titanium4, 12 weeksHematoxylin-Eosin- Safran; Masson’s Trichrome; Toluidine blue/basic fuchsineNoBIC50[102]Janner et al.2018Dog60Titanium; Zirconia4, 16 weeksToluidine blue/ McNeal combined with basic fuchsinNoBIC, BD51[103]Jimbo et al.2014Sheep48Titanium3, 6 weeksStevenel’s blueNoBIC, BAFO52[104]Jimbo et al.2014Sheep48Titanium3, 6 weeksToluidine blueNoBIC, BAFO53[105]Jimbo et al.2014Sheep48Not stated3, 6 weeksToluidine blueNoBIC, BAFO54[106]Jimbo et al.2014Dog72Titanium1, 5 weeksToluidine blueNoBIC, BAFO55[107]Kämmerer et al.2020Minipig36Titanium2, 4, 8 weeksToluidine blueNocBIC, aBIC56[108]Kim et al.2020Dog12Titanium2, 3, 4, 6 weeksMultiple Stain Solution (MSS)NoBIC, BA57[109]Kim et al.2021Rabbit8 8Titanium; Zirconia4 weeksMasson’s trichromeNoBIC, BA58[110]Kim et al.2022Rabbit39Titanium4 weeksHaematoxylin and EosinNoBIC, BA59[111]Kohal et al.2016Human22Zirconia2, 4 weeksToluidine blue and pararosanilineNoBIC, BD 60[112]Korn et al.2019Rat64Titanium2, 4 weeksMasson-Goldner trichromeNoBIC, BA/TA61[113]Kubasiewicz-Ross et al.2018Minipig60Titanium; Zirconia12 weeksMasson–Goldner trichromeNoBIC62[114]Kuo et al.2017Minipig44Titanium; Zirconia8, 16 weeksMasson–Goldner trichromeNoBIC63[115]Kwak et al.2022Rabbit32Titanium2, 4 weeksMasson–Goldner trichromeNoBIC64[116]Lang et al.2023Dog64Titanium2, 6 weeksBasic fuchsin and Toluidine blue/McNealNoBIC65[117]Lee et al.2015Rabbit10Titanium1 weekHaematoxylin and EosinNoBIC, BA66[118]Lee et al.2019Dog54Titanium2, 4, 12 weeksMasson–Goldner trichromeNob-MBL, l-MBL, mBIC, OIC, tBIC, mBAFO, OAFO, tBAFO67[119]Lee et al.2014Minipig24Not stated4 weeksHaematoxylin and EosinYesBIC68[120]Lee et al.2014Rabbit10Titanium4 weeksHaematoxylin and EosinYesBIC69[121]Lopez et al.2017Sheep24Not stated3, 6 weeksStevenel’s Blue and Van Gieson.NoBIC, BAFO70[122]Lyu et al.2021Rabbit18Titanium4 weeksHaematoxylin and EosinYes NoBIC71[123]Madi et al.2016Dog32Titanium4 monthsToluidine blueNoBIC72[124]Makary et al.2023Human35Titanium4, 6 weeksazure II/methylene blue and fuchsine acidNoBIC73[125]Martins et al.2018Rabbit30Titanium; Zirconia8 weeksToluidine blueNoBIC, BA74[126]Mehl et al.2016Minipig64Titanium6 monthsToluidine blueNoBIC75[127]Mehl et al.2018Minipig48Titanium6 monthsToluidine blueNoBIC76[128]Moest et al.2014Pig54Titanium14 and 28 daysToluidine blueYes NoBIC77[129]Neiva et al.2016DogNot statedTitanium6 weeksStevenel’s Blue and Van GiesonNoBAFO78[130]Neldam et al.2017Goat35Titanium20 weeksToluidine blueYesBIC79[131]Nevins et al.2020Human8Titanium6 monthsLevai–LaczkoYesBIC80[132]Offermanns et al.2018Rabbit72Titanium2, 12 weeksToluidine blueNoBIC, BF81[133]Offermanns et al.2018Rabbit24Titanium2 weeksToluidine blueNoBIC, BF82[134]Pinheiro et al.2014Rabbit12Titanium3 weeksStevenel’s blue and Alizarin redNoBIC83[135]Rahmati et al.2020Dog36Titanium4 weeksLevai–LaczkoNoBIC, BA84[136]Raita et al.2014Rat18Titanium3, 9 weeksMethylene blue and Basic fuchsinNoBIC, BM85[137]Reinedahl et al.2019Rabbit40Titanium8 weeksToluidine blue mixed with Pyronin GNoBIC86[138]Salou et al.2015Rabbit16Titanium2, 4 weeksmethylene blue/basic fushinNoBIC87[139]Sam et al.2020Human20Titanium8 weeksToluidine blueNoBIC, BF88[140]Sanz-Esporrin et al.2021Dog80Titanium2 and 8 weeksLevai–LaczkoNoBIC89[141]Sanz-Martin et al.2017Dog32Titanium4 and 12 weeksLevai–LaczkoNoBIC90[142]Sarendranath et al.2015Dog72Titanium3 and 5 weeksStevenel’s blue and Van GeisonNoBIC, BAFO91[143]Saulacic et al.2014Minipig72Zirconia1, 2, 4, 8 weeksToluidine blueNoBIC, BA92[144]Schmitt et al.2016Dog80Titanium2 and 7 days, and 6 monthsToluidine blueNoBIC93[145]Skiba et al.2023Human6Titanium60 daysStevenel’s blue and alizarin redNoBIC94[146]Spin-Neto et al.2014Human34Titanium4 and 6 monthsToluidine blueYesBIC, BA95[147]Stocchero et al.2018Sheep48Titanium5 and 10 weeksToluidine blue and pyronin GNotBIC, newBIC, BAFO96[148]Stoc-chero et al.2019Sheep40Titanium5 weeksToluidine blue and pyronin GNoBIC, BAFO97[149]Stokholm et al.2014Monkey20Titanium3 and 6 monthsBasic fuchsin and counterstaining with light greenNoBIC98[150]Streckbein et al.2014Dog44Titanium6, 12 weeksToluidine blueNoBIC99[151]Suaid et al.2014Dog64Titanium12 weeksToluidine blueYes NoBD, VCBR, CR100[152]Susin et al.2019Minipig70Titanium6, 12 weeksSanderson’s RBS stain and acid fuchsinNoBIC, first BIC, CBL, BDOT, BDWT101[153]Thoma et al.2015Dog48Titanium; Zirconia6 monthsvan GiesonNoBIC102[154]Thoma et al.2019Dog30Titanium; Zirconia2 weeks and 6 monthsvan GiesonNoBIC103[155]Valles et al.2018Dog60Titanium6 monthsLevai–LaczkoNoIS–BIC, IS–BC104[156]Velasco-Ortega et al.2019RabbitNot statedTitanium12 weeksLevai–LaczkoNoBIC, BV/TV105[157]Velasco-Ortega, E.2021Rabbit20Titanium12 weeksLevai–LaczkoNoBIC106[158]Verket et al.2014Minipig16Titanium6 weeksHematoxylin and EosinYesBIC107[159]Verket et al.2016Minipig16Titanium3 monthsHematoxylin and EosinYesBIC108[160]Veronesi et al.2017Rabbit14Titanium2, 4, 8 weeksToluidine blue and Fast greenNoBIC109[161]Vignoletti et al.2019DogNot statedZirconium2, 8 weeksLevai–LaczkoNoBIC110[162]Von Wilmowsky et al.2016Pig24Titanium90 daysToluidine blueYes NoNBH, NFB, BIC-D, BIC-L, BD-D, BD-L, BM-D, BM-L111[163]Wang et al.2016Rabbit24Titanium4, 8 weeksToluidine blueNoBIC112[164]Witek et al.2020Sheep40Titanium3 and 6 weeksStevenel’s Blue and Van Gieson’s Picro FuschinNoBIC, BAFO113[165]Yagi et al.2017Rat36Titanium2, 4 weeks Methylene blue and Basic fuchsinNoBIC, BM114[166]Yoo et al.2015Sheep72Titanium3, 6 weeks Stevenel’s blue and van Gieson’s picrofuchsinNoBIC, BAFO115[167]Zhou et al.2017Minipig72Titanium3, 6, 12 weeksLevai–LaczkoNorB.Ar, sBV/BV, Rm.N/Im.BdaBIC—percentage area coverage of bone-to-implant contact within representative bone chambers, b-MBL—vertical marginal bone loss at the buccal aspect of the implant, BA—bone area, BA/TA—cancellous bone area per tissue area, BABT—bone area between threads, BAD—bone area density, BAF—bone area fraction, BAFO—bone area fraction occupancy, BAMA—bone area within mirror area, BC-BD—the bone crest and the bottom of the bone defect, BD-D—bone density defect, BD-L—bone density local bone, BDOT—bone density outside the implant threads, BDWT—bone density within the implant threads, BIC—bone to implant contact, BIC-D—bone to implant contact defect, BIC-L—bone to implant contact local bone, BF—new bone formation, BM—bone mass, BM-D—bone mineralization defect, BM-L—bone mineralization local bone, BR-FE—bone resorption around the implants- free-ends’ regions, BR-I—bone resorption around the implants-inter implant region, BV/TV—bone volume per tissue volume, c-BIC—crestal bone-to-implant contact, cBIC—percentage area coverage of cortical bone-to-implant, CBL—crestal bone loss, Ct.Th—cortical bone thickness, CTIC—connective tissue-to-implant contact, CBL—vestibular and lingual crestal bone loss, CBR—crestal bone resorption between implants, CR—crestal resorption, DL—defect length, l-MBL—the vertical marginal bone loss at the lingual aspect of the implant, imp-BC—the implant surface and the alveolar bone crest, HBA—horizontal bone apposition, ISA—total implant surface available, ISB—Linear surface of the implant in direct contact with bone, IS-BC—implant shoulder to bone crest level, IS-BD—the implant shoulder and bottom of the bone defect, IS-BIC—implant shoulder to first bone-to-implant contact, LB—area of lamellar bone interthread regions/total interthread area, mBAFO—mineralized bone area fraction occupied, mBIC—mineralized bone-to-implant contact, MIC—marrow to implant contact, NBA—new bone area, NBF—newly formed bone, NBH—new bone height, OAFO—osteoid area fraction occupied, OIC—osteoid-to-implant contact, PIBA—peri-implant bone-area, rB.Ar—area of remodeled bone, RB—residual bone, RG—area residual graft particles interthread regions/total interthread area, Rm.N/Im.Bd—number of remodeling sites at the implant interface, sBV/BV—percentage of remodeled bone, STM—area of soft tissue interthread regions/total interthread area, tBAFO—total bone area fraction occupied, tBIC—total bone to implant contact, TbTh—trabecular thickness, TbSp—trabecular separation, VCBR—vertical crestal bone resorption, WB—area of woven bone interthread regions/total interthread area. Articles included in the present study. aBIC—percentage area coverage of bone-to-implant contact within representative bone chambers, b-MBL—vertical marginal bone loss at the buccal aspect of the implant, BA—bone area, BA/TA—cancellous bone area per tissue area, BABT—bone area between threads, BAD—bone area density, BAF—bone area fraction, BAFO—bone area fraction occupancy, BAMA—bone area within mirror area, BC-BD—the bone crest and the bottom of the bone defect, BD-D—bone density defect, BD-L—bone density local bone, BDOT—bone density outside the implant threads, BDWT—bone density within the implant threads, BIC—bone to implant contact, BIC-D—bone to implant contact defect, BIC-L—bone to implant contact local bone, BF—new bone formation, BM—bone mass, BM-D—bone mineralization defect, BM-L—bone mineralization local bone, BR-FE—bone resorption around the implants- free-ends’ regions, BR-I—bone resorption around the implants-inter implant region, BV/TV—bone volume per tissue volume, c-BIC—crestal bone-to-implant contact, cBIC—percentage area coverage of cortical bone-to-implant, CBL—crestal bone loss, Ct.Th—cortical bone thickness, CTIC—connective tissue-to-implant contact, CBL—vestibular and lingual crestal bone loss, CBR—crestal bone resorption between implants, CR—crestal resorption, DL—defect length, l-MBL—the vertical marginal bone loss at the lingual aspect of the implant, imp-BC—the implant surface and the alveolar bone crest, HBA—horizontal bone apposition, ISA—total implant surface available, ISB—Linear surface of the implant in direct contact with bone, IS-BC—implant shoulder to bone crest level, IS-BD—the implant shoulder and bottom of the bone defect, IS-BIC—implant shoulder to first bone-to-implant contact, LB—area of lamellar bone interthread regions/total interthread area, mBAFO—mineralized bone area fraction occupied, mBIC—mineralized bone-to-implant contact, MIC—marrow to implant contact, NBA—new bone area, NBF—newly formed bone, NBH—new bone height, OAFO—osteoid area fraction occupied, OIC—osteoid-to-implant contact, PIBA—peri-implant bone-area, rB.Ar—area of remodeled bone, RB—residual bone, RG—area residual graft particles interthread regions/total interthread area, Rm.N/Im.Bd—number of remodeling sites at the implant interface, sBV/BV—percentage of remodeled bone, STM—area of soft tissue interthread regions/total interthread area, tBAFO—total bone area fraction occupied, tBIC—total bone to implant contact, TbTh—trabecular thickness, TbSp—trabecular separation, VCBR—vertical crestal bone resorption, WB—area of woven bone interthread regions/total interthread area. The study results demonstrated that most of the in vivo experiments utilized animal rather than human models (Figure 2), with dog, rabbit, and pig models being the most commonly used (in more than 70% of the cases), followed by rat, sheep, goat, and monkey models (Figure 3). Distribution of animal and human trials. Distribution of animal experiments. As for the staining methods, the most commonly used were toluidine blue (alone or with different counterstains), Stevenel blue with Van Gieson, and Levai–Laczko (Figure 4). Histological staining techniques for bone histomorphometric analysis of osseointegrated intraosseous dental implants. * Toluidine blue in combination with other dyes such as pararosaniline, pyronin, fast green, basic fuchsin, and Giemsa solution ** van Gieson, Alizarin red, Methylene blue-Alizarin red, MOVAT Pentachrome (after Verhöff), Fibrin stain of Ladewig, Picro-syrius-Hematoxylin, Basic fuchsin and Light green, Hematoxylin-Eosin-Safran, Sanderson’s RBS stain and acid fuchsin. This scoping review indicates that the most frequently evaluated histomorphometric parameters were BIC (in more than 90% of studies), BAFO, BA, and BD. The definitions of BAFO, BA, and BD, however, suggest that they are usually equivalent terms that describe the ratio between the area occupied by bone and the total area. The only difference seems to be the type of bone area considered. Some authors considered the whole bone area [57,59,60,64,69,87,90,92,103,104], whereas others considered only mineralized bone [76,80,81,88,97,98]. The region of interest is a specific zone that is the target of assessments and analysis. Some authors clearly defined the ROI, while others did not specify what ROI was used in their research. Table 2 shows the definitions of the ROIs from the studies included in this review, when present, as well as the observed histomorphometric parameters. Table 2Regions of interest (ROIs) and the evaluated histomorphometric parameters.№ReferenceAuthorsYearRegion of Interest (ROI)Histomorphometric Parameter1[57]Al-Omari et al.2020The regions around the dental implant—between 0 μm and 1000 μm away from the implant surface horizontally and from the implant shoulder up to 2500 μm below the implant platform longitudinally. The ROIs for Ct.Th were at 250 μm, 500 μm, and 750 μm away from the implant surface at the study endpoint. BIC BAF Ct.Th 2[58]Alshehri et al.2019A rectangle with a length of 5 mm, equal to the porous portion of the implant, and a height of 0.5 mm (adjacent to the implant surface). PIBA 3[60]Beutel et al.2016ROI 1—the region of cortical bone. ROI 2—the region of trabecular bone. BIC BAFO 4[68]Chiu et al.2018Total implant length; the first four threads at the most coronal aspect, starting from the grafted area (4T); and the two threads (2T) apical to 4T. BIC MIC CTIC 5[70]Cho et al.2019The region from the bone crest to 2 mm in depth. BIC BA 6[72]Coelho et al.2014For BIC—the total implant perimeter. For BAFO—the total area between threads. BIC BAFO 7[75]de Barros et al.2015ROIs—for each section on each implant side (left and right). In each case, measurements were performed in the ROI directly adjacent to the implant (adjacent ROI) and one of identical shape, neighboring the adjacent ROI, at a further distance from the implant (distant ROI). Each ROI had a rectangular shape, and the adjacent ROIs included various peri-implant defects (0.5, 1.0, or 2.0 mm in width and 5 mm in distance from the implant shoulder). BD BIC 8[76]De Barros et al.2014The region between adjacent implants, using a predetermined rectangle as a frame to select the areas to be assessed. SAQW 9[80]Du et al.2015For BIC—the total implant perimeter. For BA—the total area between threads. BIC BA 10[81]Du et al.2016For BIC—the total implant perimeter. For BA—the total area between threads. BIC BA 11[82]Dundar et al.2018The total implant perimeter. BIC 12[83]Elmali et al.2020From the implant shoulder to the end of the gap (4 mm). BIC NBF 13[85]Felgueiras et al.2017The area delineated by a circle drawn at a distance of 100 µm from the implant. BIC BA 14[86]Fernández-Domínguez et al.2019For CBL—from the implant platform to the first point of bone-to-implant contact. For BIC—two regions (lingual and buccal), from the implant shoulder to the apical part CBL BIC 15[87]Fetner et al.2015For BIC—the total implant perimeter. For BA—the total area between threads. BIC BAFO 16[88]Freitas et al.2016ROI—from the first thread down toward the fourth one, both medially and distally. For BIC and BABT—the area between threads. For BAMA—the area outside the threads. This mirror area is a symmetrical area to the trapezoid between two threads, sharing its larger base. BIC BABT BAMA 17[89]Gabler et al.2015The length of the shell area of each implant—only those parts of the implant that were completely surrounded by bone tissue. BIC 18[90]Galárraga-Vinueza et al. 2020The residual bone was divided into 500 μm-wide horizontal zones following the long axis of the implant. DL RB BIC B.Ar/T.Ar 19[92]Gil et al.2016For BIC—the total implant perimeter. For BAFO—the total area between threads. BIC BAFO 20[97]Gurzawska et al.2017For BIC—a zone from the upper level of the cortical bone to half of the length (between the second and third thread). For BD—the region within two threads in the cortical bone. BIC BD 21[99]Hirota et al.2014The total implant perimeter. BIC BM 22[111]Kohal et al.2016For BIC—from the first bone-to-implant contact point to the apical part of the implant on both sides. For BA—the area within the implant threads on both sides of each implant. BIC BA 23[117]Lee et al.2015The range of 2 mm below the upper bone crest. BIC BA 24[118]Lee et al.2019The peri-implant area, located between 3 and 6 mm below the implant shoulder. b-MBL l-MBL mBIC OIC tBIC mBAFO OAFO tBAFO 25[128]Moest et al.2014Four ROIs—two in the crestal and two in the apical implant region. BIC 26[130]Neldam et al.2017The peri-implant bone. The implant was divided into two vertical zones: the micro thread area and the macro thread area BIC 27[132]Offermanns et al.2018ROIs at 0–250 μm and 250–500 μm distances from the implant surfaces. BIC BF 28[133]Offermanns et al.2018ROIs at 0–250 μm (inside the thread of the implant) and 250–500 μm (outside the thread of the implant) distances. BIC BF 29[135]Rahmati et al.2020Around the bone chamber implant (a rectangular ROI). BIC BA 30[136]Raita et al.2014The total of both the mesial and distal triangular areas formed by the threads. BIC BM 31[139]Sam et al.2020For BIC—the total length implant surface. For NBF—the total area of the implant chamber. BIC NBF 32[140]Sanz-Esporrin et al.2021The most coronal portion (3 mm) and the entire surface (6 coronal mm) of the implant. BIC 33[142]Saulacic et al.2014The surface of the implant groove and the extension of the outer implant diameter. BIC BA 34[144]Schmitt et al.2016Regions of interest: ROIs 1 and 4 in the gap of the middle part of the implant, ROIs 2 and 3 in the threaded apical part, and ROI 5 at the tip of the implant. BIC 35[145]Skiba et al.2023The whole implant perimeter. BIC 36[146]Spin-Neto et al.2014On each side of the mini-implant, three equally sized regions (length: 650 lm; area: 3500 lm2) were traced, representing the “coronal” (R1), “middle” (R2), and “apical” (R3) portions of the mini-implant (corresponding to threads 1–2, 7–8, and 13–14 from the head of the screw, respectively). BA BIC 37[150]Streckbein et al.2014The total implant surface area. BICRs 38[151]Suaid et al.2014Within a rectangle that comprises the region of the defect, 1.0 mm wide and 3 mm in length (total area obtained), from the implant shoulder (adjacent areas) and also within another in a mirror image of the first areas (distant areas). BD 39[153]Thoma et al.2015The ROI was defined with a length of 4 mm in the center on the buccal and lingual sides of each implant. BIC 40[154]Thoma et al.2019The ROI was defined with a length of 4 mm in the center on the buccal and lingual sides of each implant. BIC 41[161]Vignoletti et al.2019At the most coronal portion (3 mm) as well as the overall dimension of the implant. BIC 42[167]Zhou et al.2017A 200 µm-wide zone parallel to the implant surface from the implant shoulder downward. rB.Ar sBV/BV B.Ar Rm.N/Im.Bd BA—bone area, BABT—bone area between threads, BAF—bone area fraction, BAFO—bone area fraction occupancy, BAMA—bone area within mirror area, B.Ar—total bone area, B.Ar/T.Ar—bone density, BD—bone density, BF—new bone formation, BIC—bone to implant contact, BICRs—bone to implant contacts, BM—bone mass, b-MBL—vertical marginal bone loss at the buccal aspect of the implant, CBL—crestal bone loss, CTIC—connective tissue to implant contact, CT.Th—cortical bone thickness, DL—defect length, l-MBL—the vertical marginal bone loss at the lingual aspect of the implant, mBAFO—mineralized bone area fraction occupied, mBIC—mineralized bone to implant contact, MIC—marrow to implant contact, NBF—newly formed bone, OAFO—osteoid area fraction occupied, OIC—osteoid to implant contact, PIBA—peri-implant bone area, RB—residual bone, rB.Ar—area of remodeled bone, Rm.N/Im.Bd—number of remodeling sites at the implant interface, sBV/BV—percentage of remodeled bone, tBAFO—total bone area fraction occupied, tBIC—total bone to implant contact. Regions of interest (ROIs) and the evaluated histomorphometric parameters. BA—bone area, BABT—bone area between threads, BAF—bone area fraction, BAFO—bone area fraction occupancy, BAMA—bone area within mirror area, B.Ar—total bone area, B.Ar/T.Ar—bone density, BD—bone density, BF—new bone formation, BIC—bone to implant contact, BICRs—bone to implant contacts, BM—bone mass, b-MBL—vertical marginal bone loss at the buccal aspect of the implant, CBL—crestal bone loss, CTIC—connective tissue to implant contact, CT.Th—cortical bone thickness, DL—defect length, l-MBL—the vertical marginal bone loss at the lingual aspect of the implant, mBAFO—mineralized bone area fraction occupied, mBIC—mineralized bone to implant contact, MIC—marrow to implant contact, NBF—newly formed bone, OAFO—osteoid area fraction occupied, OIC—osteoid to implant contact, PIBA—peri-implant bone area, RB—residual bone, rB.Ar—area of remodeled bone, Rm.N/Im.Bd—number of remodeling sites at the implant interface, sBV/BV—percentage of remodeled bone, tBAFO—total bone area fraction occupied, tBIC—total bone to implant contact. 4. Discussion Animal testing has been regarded as a reliable method for biomedical research and a prerequisite to human clinical trials. Animals are used as in vivo models in order to obtain results for translation to clinical settings. This requires a precise selection of animal models based on their resemblance to the human organism. In the fields of biomedicine and biomaterials science, animal models are used to reproduce the biological and physiological pathways of humans. However, animal species differ significantly from humans regarding their anatomical features and physiological reactions. Therefore, a careful selection of the most appropriate animal model for each study is required [45]. A wide range of species has been used for these purposes through the years, from small laboratory rodents to larger animals such as dogs, pigs, and non-human primates [32,44,45]. By mimicking the biological environment in humans, pre-clinical trials allow for the investigation of the interaction between implants and peri-implant tissues. All animal models have some advantages and disadvantages. However, none of them can sufficiently represent all levels (macro, micro, and nano) of implant osseointegration [45]. It has been reported that the most commonly used animal models for implant biomaterial research are dogs, sheep, pigs, rabbits, goats, and rodents [31,168]. According to the findings in this scoping review, dogs are the most frequently used animals, followed by rabbits, pigs, rats, sheep, goats, and monkeys. Dog models are often preferred due to their larger size and the resemblance of their bone morphology and mineral density to those of humans. A major drawback is the variable inter-individual and intra-individual trabecular bone turnover [33]. Rabbit models are cost-effective, non-aggressive, and easy to house and handle. They reach their skeletal maturity at 6 months, which allows for fast experimental results. However, their rapid bone remodeling and turnover differ significantly from those of human bones [33]. Pigs as animal models have numerous advantages, such as their size, well-developed Haversian systems, and similar bone mineral density and bone mineral concentration to those of humans. In addition, they demonstrate similar bone remodeling processes and bone regeneration rates. However, they are more aggressive and difficult to handle [33]. Rat models are cost-effective and easy to handle. Their major drawbacks are their small size, which provides a limited surgical area; rapid metabolic rate; and higher osteogenic potential than that of humans. Furthermore, their bone morphology and mineral density differ from those of humans [33]. Sheep have similar bone turnover and remodeling rates to those of humans. However, their bone microstructure differs significantly from that of humans. Moreover, sheep undergo seasonal periods of bone resorption [33]. Non-human primates have been utilized due to their morphological and genetic resemblance to humans. Recently, they have almost stopped being used for such purposes due to ethical reasons and housing difficulties [46]. In recent years, advances in biomedical research have led to the progressive replacement of animal testing by using in vitro experiments and biomaterial strategies, thus avoiding animal sacrifice. In 2011, Lang et al. [169] demonstrated that the process of osseointegration in humans is slower when compared with what had been previously reported in animal models, such as dogs [170] and minipigs [171]. Therefore, the authors concluded that a direct comparison between the results from human and animal studies, using BIC as a marker of osseointegration, is impossible. Most of the studies included in this review evaluated dental implants made of titanium rather than zirconia, which could indicate that titanium remains the gold standard for the fabrication of dental implants. Undecalcified bone histology and histomorphometry provide essential information on bone quality and quantity [29]. Plastic embedding allows for the observation and assessment of peri-implant tissues in undecalcified bone specimens [29,168,172]. This method provides the structural preservation and stabilization necessary for static and dynamic histomorphometric evaluation [29,173,174,175,176,177]. Almost all histological staining methods can be used for bone histological and histomorphometric assessment. The results of this review demonstrate that the most commonly used staining techniques for bone histomorphometric analysis of osseointegrated intraosseous dental implants are toluidine blue, Stevenel’s blue with Van Gieson, and Levai–Laczko. Toluidine blue staining provides clear identification of mineralized bone, osteoid tissue, and soft tissues [29,178,179,180]. Furthermore, this method allows for the observation of osteons and cement lines [29,170,180,181,182,183,184], which mark the line between old and newly formed bone, and has been successfully utilized for the evaluation of the bone–implant interface [29,60,73,185,186,187,188,189]. The aim of staining bone specimens is to visualize the healing process, the areas of new bone formation, and the inflammatory response within the defect. The hematoxylin-and-eosin staining technique is usually utilized for the establishment of material safety, while Stevenel’s blue and Goldner’s trichrome stainings can be used for the evaluation of their efficacy. Hematoxylin-and-eosin staining is commonly used for the assessment of inflammatory reactions and biocompatibility [33]. However, it does not allow for a clear distinction between pre-existing and newly formed bone. Therefore, the utilization of additional stains is necessary for the visualization of new bone apposition. A wide range of staining methods, such as von Kossa, Alizarin Red, Goldner’s trichrome, van Gieson, Stevenel’s blue, Safranin O/Fast green, and so on, can be used for plastic-embedded specimens [32]. Stevenel’s blue with van Gieson’s picrofuchsin as a counterstain provides excellent identification of pre-existing bone and areas of new bone formation. However, the distinction between osteoid and soft tissues can be difficult [33]. Van Gieson staining can be successfully used for the assessment of the bone–implant interface. Stevenel’s blue staining provides a visualization of fibrous tissue [33]. Levai–Laczko staining provides a visualization of the areas of old bone, newly formed bone, and bone-grafting materials. Quantitative bone histomorphometry requires a distinction between osteoid and mineralized bone. Several staining techniques can be used for this purpose, such as methylene blue basic fuchsin, von Kossa with hematoxylin and eosin counterstaining, Goldner’s trichrome, and Sanderson’s rapid bone with either acid fuchsin or van Gieson counterstaining [33]. Computer-assisted histomorphometric evaluation requires the use of staining protocols that provide different stainings of bone microstructures. Therefore, the “perfect” staining method should allow for an excellent distinction between these units. In addition, it should have the following advantages: reproducibility, ease of use, and cost-effectiveness. Numerous histomorphometric parameters have been used for the evaluation of implant osseointegration, the bone–implant interface, material behavior, and so on. As previously stated, this review indicates that the most commonly used histomorphometric parameter is BIC, which is calculated as the region of such contact along the implant perimeter subtracted from the total implant perimeter. This parameter has been used as a reliable marker of osseointegration and implant stability [190]. Most authors have suggested similar definitions for BA, BD, and BAFO, and used them to calculate the ratio between the bone area and total area in ROIs. There are some discrepancies regarding the definitions of the above-mentioned histomorphometric parameters among studies. This requires either unification of the terminology or a clear explanation of the exact protocol and methodology in each study. The region of interest is the specific target area of evaluation and analysis. As can be seen in Table 2, even when examining the same histomorphometric parameters, researchers have used different ROIs. This is because ROIs are defined individually by authors and depend on the study objectives. Moreover, some authors do not define the ROI they used, which further hinders the interpretation. A comparison of the studies that have evaluated bone–implant interfaces is difficult due to differences in their methodologies, including related to in vivo models (human and animal), staining techniques, implant types and materials, histomorphometric parameters, and so on. Unification of the terminology used for bone histomorphometric assessment of dental implants could contribute to an easier interpretation and better understanding of the results. 4.1. Strengths To our knowledge, this is the first scoping review which estimates the frequency of use of the three variables: study models, staining techniques, and histomorphometric parameters. It demonstrates the trends in dental implant research for the last 10 years. In addition, some advantages and limitations of the study models, staining methods, and observed parameters are presented descriptively. Furthermore, the study summarizes the various definitions of ROI and the lack of such information in some studies, identifying a significant research gap. Understanding the histomorphometric evaluation of dental implants is essential for clinicians in the fields, as it answers questions such as: How soon after implantation can the implants carry functional loading and with what magnitude?; What is the impact of surgical trauma on the peri-implant bone and what are the parameters of the postoperative healing process?; What is the influence of the implant macro design and biomaterial, and the modification of its surface topography and chemistry on the peri-implant healing processes, their speed, qualities, and predictability? 4.2. Limitations A limitation of this scoping review is that a risk of bias assessment of the included studies and a meta-analysis of the results were not performed. This is mainly due to the specificity of the review question, as it focuses on the frequency of use and trends in the field and compares the methodologies used in the studies, not their outcomes. Furthermore, the results of this review show the recent trends but do not explain the rationale for them. The timeframe of 10 years was selected in this review in order to filter the state-of-the-art protocols for histomorphometric evaluation of dental implant osseointegration and identify the contemporary approaches in the field. Changes in the ethical requirements through the years and the efforts towards reducing the use of animal models have influenced the choice of study models. In addition, the introduction of different biomimetic approaches, including new implant coatings and other implant surface modifications, has led to a growing number of studies on the topic, summarizing the previous knowledge and presenting the most recent protocols. As Babuska et al. indicated, developing biomimetic implant surfaces that resemble natural tissues is an important research topic [35]. The paraffin histology widely used in the past poses the risk of tissue impairment during decalcification. Moreover, embedded hard objects like implants are usually detached from the tissues during paraffin sectioning. The application of resins as embedding media greatly facilitates the histological and histomorphometric studies of osseointegrated dental implants [35]. 4.3. Future Directions Further research, including randomized clinical trials, systematic reviews, and meta-analyses, is necessary to define the most appropriate protocols for the histomorphometric evaluation of osseointegrated intraosseous dental implants. Unification of the histomorphometric terminology and clear guidelines for using the different histomorphometric parameters are required. 5. Conclusions This scoping review identifies the most frequently used staining method (toluidine blue), study model for in vivo experiments (dog), and histomorphometric parameters (BIC) for the assessment of the osseointegration of dental implants in the past 10 years. The study demonstrates the recent trends in the field rather than the scientific rationale for their use. Unification of the terminology with clear guidelines for using the different histomorphometric parameters and optimization of the suggested protocols are necessary for easier interpretation and better understanding. Acknowledgments It is a pleasure for the authors to acknowledge help and encouragement from Tsanka Dikova. Author Contributions Conceptualization, S.P.; methodology, R.Y. and I.P.; software, I.P. and R.Y.; validation, S.P., R.Y. and I.P.; formal analysis, S.P., R.Y. and I.P.; investigation, R.Y. and I.P.; resources, S.P.; data curation, S.P., R.Y. and I.P.; writing—original draft preparation, I.P. and R.Y.; writing—review and editing, S.P., R.Y. and I.P.; visualization, R.Y. and I.P.; supervision, S.P.; project administration, S.P.; funding acquisition, S.P. All authors have read and agreed to the published version of the manuscript. Data Availability Statement The original data presented in the study are openly available in the Open Science Framework (OSF) and can be found at https://archive.org/details/osf-registrations-9b8yx-v1 (accessed on 12 July 2024). Conflicts of Interest The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results. Funding Statement This study is financed by the European Union-NextGenerationEU, through the National Recovery and Resilience Plan of the Republic of Bulgaria, Project No. BG-RRP-2.004-0009. Footnotes Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. References Associated Data Data Availability Statement The original data presented in the study are openly available in the Open Science Framework (OSF) and can be found at https://archive.org/details/osf-registrations-9b8yx-v1 (accessed on 12 July 2024).